Outcomes of mitral valve re-replacement for bioprosthetic structural valve deterioration

被引:15
|
作者
Javadikasgari, Hoda [1 ]
Chemtob, Raphaelle A. [1 ]
Gillinov, A. Marc [1 ]
Pettersson, Gosta B. [1 ]
Lowry, Ashley M. [3 ]
Desai, Milind Y. [2 ]
Svensson, Lars G. [1 ]
Blackstone, Eugene H. [1 ,3 ]
Wierup, Per [1 ]
机构
[1] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Heart Vasc & Thorac Inst, 9500 Euclid Ave,Desk J4-1, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Cardiovasc Med, Heart Vasc & Thorac Inst, Cleveland, OH 44195 USA
[3] Cleveland Clin, Dept Quantitat Hlth Sci, Res Inst, Cleveland, OH 44195 USA
来源
关键词
heart valve replacement; outcomes research; causes of death; survival; RISK-FACTORS; SURGERY; IMPLANTATION; SOCIETY; GUIDELINES; EXPERIENCE; GRADIENT;
D O I
10.1016/j.jtcvs.2020.08.067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Reoperation for structural valve deterioration (SVD) of bioprosthetic mitral valves carries a presumed high operative risk, and transcatheter mitral valve-in-valve implantation has emerged as an alternative. However, surgical risk and long-term outcome following mitral valve re-replacement in these patients remain ill-defined. Hence, we sought to evaluate outcomes and long-term survival following surgical mitral valve re-replacement and to identify risk factors for mortality. Methods: From January 1990 to January 2017, 525 patients underwent surgical mitral valve re-replacement at Cleveland Clinic for bioprosthetic SVD: 133 (25%) isolated operations and 392 (75%) with concomitant procedures. Surgical complications and modes of death were compiled, long-term mortality assessed, and risk factors identified using a multivariable nonproportional hazards model and random forest analysis. Results: SVD was characterized by bioprosthetic regurgitation in 81% (425 out of 525) and stenosis in 44%(231 out of 525). One in-hospital death occurred after isolated valve re-replacement (0.75%) and 28 deaths occurred (7.1%; P =.003) after nonisolated re-replacement, 19 (68%) of which were from coagulopathy, vasoplegia, and multisystem organ failure. In the nonisolated group, incremental risk factors for time-related death after re-replacement included New York Heart Association functional class IV symptoms, concomitant coronary artery bypass grafting, prolonged cardiopulmonary bypass time, and transfusions. Conclusions: Mitral valve re-replacement for bioprosthetic SVD was associated with low surgical risk and excellent long-term survival. Isolated mitral valve re-replacement for bioprosthetic SVD had near-zero surgical risk. Excessive cardiopulmonary bypass duration and multiple transfusions correlated with increased early mortality in nonisolated procedures, as did preoperative severe heart failure. Optimal surgical plan and timing of surgery are keys to success.
引用
收藏
页码:1804 / +
页数:14
相关论文
共 50 条
  • [41] Bioprosthetic Tricuspid Valve Stenosis in a Case of Rheumatic Mitral Valve Stenosis and Tricuspid Valve Replacement
    Sapkal, Ganeshrao
    Sharma, Satyavan
    JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2022, 8 (03) : 182 - 184
  • [42] Impact of Bioprosthetic Valve Fracture on Hemodynamics in Transseptal Mitral Valve- in-Valve Replacement
    Isogai, Toshiaki
    Misra, Rohit
    Shekhar, Shashank
    Kaur, Simrat
    Agrawal, Ankit
    Yun, James J.
    Unai, Shinya
    Burns, Daniel J. P.
    Kapadia, Samir R.
    Krishnaswamy, Amar
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (23) : 2942 - 2944
  • [43] Structural valve deterioration after aortic valve replacement with the Trifecta valve
    Werner, Paul
    Gritsch, Jasmin
    Scherzer, Sabine
    Gross, Christoph
    Russo, Marco
    Coti, Iuliana
    Kocher, Alfred
    Laufer, Guenther
    Andreas, Martin
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2021, 32 (01) : 39 - 46
  • [44] Outcomes of Valve-in-Valve Transcatheter Aortic Valve Replacement With and Without Bioprosthetic Valve Fracture
    Brinkmann, Christina
    Schofer, Joachim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (19) : B9 - B9
  • [45] Early Structural Deterioration of a Sutureless Bioprosthetic Aortic Valve
    Cinelli, Michael
    Schwartz, Leonard
    Spagnola, Jonathan
    Gulkarov, Iosif
    Rosell, Frank
    Lackey, Adam
    Imam, Mohammed
    Schwartz, Charles
    CARDIOLOGY RESEARCH, 2020, 11 (02) : 113 - 117
  • [46] 5-year outcomes of patients with mitral structural valve deterioration treated with transcatheter valve in valve implantation
    Pravda, N. Schamroth
    Mishaev, R.
    Levi, A.
    Witberg, G.
    Shapira, Y.
    Orvin, K.
    Barkan, Y. Talmor
    Hamdan, A.
    Sharoni, R.
    Perl, L.
    Sagie, A.
    Assa, H. Vaknin
    Kornowski, R.
    Codner, P.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2113 - 2113
  • [47] Apicoaortic bypass for a patient with structural valve deterioration of a 19 mm bioprosthetic valve
    Domoto, Satoru
    Tagusari, Osamu
    Nakamura, Yoshitsugu
    Seike, Yoshimasa
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2012, 14 (01) : 105 - 107
  • [48] Incidence, Predictors, and Impact of Bioprosthetic Valve Hemodynamic Deterioration Following Aortic Valve Replacement
    Salaun, Erwan
    Mahjoub, Haifa
    Girerd, Nicolas
    Dagenais, Francois
    Voisine, Pierre
    Mohammadi, Siamak
    Kalavrouziotis, Dimitris
    Yanagawa, Bobby
    Verma, Subodh
    Clavel, Marie-Annick
    Pibarot, Philippe
    CIRCULATION, 2017, 136
  • [49] Outcomes of pulmonary valve replacement using a PTFE bicuspid valve versus a bioprosthetic valve
    Al-Ayoubi, Adnan M.
    Ricci, Marco
    JOURNAL OF CARDIAC SURGERY, 2021, 36 (11) : 4176 - 4177
  • [50] Early double valve re-replacement after Ross operation
    Oezkara, Ahmet
    Guenay, Ilhan
    Cetin, Guerkan
    Mert, Murat
    Sar, Mehmet
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2007, 7 (02): : 196 - 198